In order to facilitate the elucidation of the biological functions of SMN in different pathways and molecular etiology of SMA, we set out to develop SMN-specific chemical probes, and identified compound 1, a 2.6 μM antagonist. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.